The 7th BioProScale Symposium took place again as in-person event in Berlin

New ways of thinking are required: Scientists from both academia and industry presented and discussed innovative approaches and developments in biotechnology and bioprocess engineering

12-Apr-2022 - On the subject of “Scaling Up and Down of Bioprocesses: Technological Innovation and Cell Physiology Insights”,the 7thSymposium was again held on-site in Berlin from March 28 to31,2022. In parallel, there was also the possibility to follow the presentations online. The symposium was organized ...

LabCentral Announces $22.4 Million in Committed Funding for LabCentral 238 including New Sponsors Thermo Fisher Scientific and Waters Corporation

Scale-up bio-manufacturing facility is expected to open in November 2021

01-Mar-2021 - LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. Thermo ...

Evolva in collaboration with Roquette

04-Jan-2012 - Evolva Holding SA announced the signing of an agreement with Roquette Frères SA for joint research and development of novel and optimised biosynthetic production routes for an ingredient with important applications in food products.The collaboration will run for up to 4.5 years and involve c. 7% ...

Purac investigates participation in Bioprocess Pilot Facility

03-May-2011 - Purac is investigating the participation in a multi-purpose Bioprocess Pilot Facility (BPF) in a consortium of a number of industry partners and universities, including DSM and Delft University of Technology.This Bioprocess Pilot Facility is planned to be built in Delft, The Netherlands and aimed ...

KTH Royal Institute of Technology: World record in DNA analysis

21-Mar-2011 - To date, scientists have been limited to running a small number of DNA samples at a time at a cost of SEK 100,000 per sample. KTH researchers have now come up with a new method which means that 5,000 samples can be run simultaneously for the same price. This cuts the cost per test result ...

Novartis unveils long-term strategy to grow in a dynamically changing healthcare environment

Cornerstone of Novartis strategy is focus on innovation through most productive R&D program in the industry

19-Nov-2010 - Novartis presented a strategic overview of the company's diversified healthcare portfolio which creates the potential for future sustainable growth. The company's focused healthcare portfolio across key growth segments in healthcare provides Novartis a leading position in the respective market ...

Novasep Process and Nutritis scale-up the production process for Nutritis’ fructose purification from substandard fruit

11-Nov-2010 - Nutritis and Novasep Process, a division of Novasep, announced that, thanks to Novasep Process, Nutritis will scale up its production process for fructose from apple juice. Nutritis brought in Novasep to use the latter’s purification expertise to scale up its innovative process. Nutritis and ...

CANDOR: Production capacity expanded by a factor of 10

01-Nov-2010 - CANDOR Bioscience has enlarged its production capacity after relocation to a larger facility in Wangen im Allgäu. “The constantly rising demands, especially for our stabilizer solutions for ELISA kit manufacturing, called for a significant enlargement of our production capacities. Kit ...

DuoCort Pharma and Recipharm start collaboration for the treatment of Addison’s disease

28-Oct-2010 - DuoCort Pharma announces it has concluded an agreement with Recipharm under which Recipharm is set to scale-up the manufacturing of DuoCort’s tablets to commercial scale as DuoCort Pharma prepares for market entry with its orphan drug for the treatment of Addison’s disease. The scale-up agreement ...

Phosphagenics moves towards scale-up patch manufacturing after positive clinical results

TPM patch profile ideal for the treatment of chronic pain

18-Oct-2010 - Melbourne drug delivery company Phosphagenics Limited is set to move from lab-scale development into commercial patch manufacturing after successfully completing its product profiling phase 1 study. This milestone study, led by Professor Guy Ludbrook at the Royal Adelaide Hospital, involved ...